ARE YOU A PATIENT LIVING WITH NAFLD/NASH OR HEALTHCARE PROFESSIONAL CARING FOR NAFLD/NASH PATIENTS?
Welcome to Fatty Liver Foundation’s LIVER (Live Interactive Virtual Education and Review) Webinar Series. This four-part webinar series will deliver the latest research and medical information, including lifestyle/diet, testing and treatment, to people living with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their medical providers. Our goal is to keep the patient community up-to-date on medical research and to build an archive of the important historical evolution of the field.
Join us for part-two of this webinar series on October 28, 2020 at 12:00 pm EDT hosted by Wayne Eskridge, our Co-Founder and CEO, along with Dr. Neeraj Mistry, our Chief Medical Officer, and a panel of leading clinicians and experts featuring Drs. Manal Abdelmalek, Amreen Dinani, and Arun Sanyal who will review and discuss highlights from the 6th Paris NASH Meeting 2020 and answer your questions.
To register for and participate in this free webinar, please visit www.fattyliverfoundation.org or email us at [email protected]. We look forward to your participation!
AGENDA*
|
12:00 pm – 12:10 pm |
WELCOME AND INTRODUCTION Host – Wayne Eskridge, Fatty Liver Foundation Moderator – Neeraj Mistry, MD, MPH, Fatty Liver Foundation |
|
12:10 pm – 12:30 pm |
SESSION 1: LIFESTYLE AND DIET New Data on Lifestyle and Dietary Interventions in NAFLD/NASH Management Presenter – Amreen Dinani, MD, Icahn School of Medicine at Mount Sinai Q&A – Neeraj Mistry, MD, MPH |
|
12:30 pm – 12:50 pm |
SESSION 2: TESTING Advances in Non-Invasive Biomarkers for Diagnosis and Monitoring of NAFLD/NASH Presenter – Arun Sanyal, MD, Virginia Commonwealth University School of Medicine Q&A – Neeraj Mistry, MD, MPH |
|
12:50 pm – 01:10 pm |
SESSION 3: TREATMENT Update on Investigational Drugs and Therapeutic Targets for NAFLD/NASH Presenter – Manal Abdelmalek, MD, MPH, Duke University Q&A – Neeraj Mistry, MD, MPH |
|
01:10 pm – 01:15 pm |
REFLECTIONS AND TAKEAWAY POINTS Wayne Eskridge |
*Subject to change. This educational program is supported by grants from Intercept Pharmaceuticals, Madrigal Pharmaceuticals, and NetNoggin. Fatty Liver Foundation maintains editorial control and independence over the educational program content.
